The tear lysozyme content in 111 normal subjects and in 159 patients with various conjunctival diseases was determined by a single radial immunodiffusion technique. Tear lysozyme 1
level in normal people was 1-33 mg/ml. (SI conversion: mg/ml=g/l.) The mean tear lysozyme levels in patients with chronic irritative conjunctivitis (097 mg/ml) and nutritional deficiency with epithelial xerosis (0-76 mg/ml) were significantly lower than in the normal controls. The mean tear lysozyme levels in tears from patients with vernal conjunctivitis (1-20 mg/ml), phlyctenular conjunctivitis (1410 mg/ml), and acute bacterial conjunctivitis (1-48 mg/ml) were not significantly different from those in the normal controls. Superimposition of acute bacterial conjunctivitis on trachoma did not alter the low tear lysozyme level that existed before in these patients. Lysozyme (muramidase) is present in high concentration in normal human tears. Its role is uncertain. In view of the bacteriolytic property of lysozyme' 2 it has generally been held that the enzyme in tears acts as a protective agent against bacterial infection.
Although there are several studies on the tear lysozyme level in keratoconjunctivitis sicca,3'0 only a few are available on it in other conjunctival diseases."'-3 The tear lysozyme level in patients with trachoma is low.'4 The purpose of the present study was 2-fold: (1) To investigate whether there is any alteration in the tear lysozyme level in patients with other conjunctival diseases, and (2) To investigate whether superimposition of acute bacterial conjunctivitis in patients with trachoma alters the existing low tear lysozyme level.
Subjects and methods
The study was carried out among 159 patients with various conjunctival diseases and 111 healthy people chosen consecutively from the Outpatient Department of Guru Nanak Eye Centre, New Delhi. The latter group served as control for all the disease groups and comprised people who had no ocular or systemic disease and had attended the hospital only for a routine check-up.
An earlier report by the present authors has already described the lysozyme level among normal Indian people by the immunoassay method.14 However, for the purpose of the present investigation it was considered advisable to examine a fresh group of normal people to serve as concurrent control. The diagnosis of conjunctival diseases was based on detailed clinical examination, including slit-lamp biomicroscopy, ophthalmoscopy, and relevant bacteriological and other laboratory investigations. The patients with chronic irritative conjunctivitis were factory workers whose eyes were exposed to noxious fumes for many months. Their chief complaints were watering, burning, stinging, foreign body sensation, and an urge to rub their eyes. Hyperaemia of the conjunctiva was a prominent clinical feature and was particularly marked in the area of the palpebral aperture. On slit-lamp examination there were no follicles, scarring of the conjunctiva, or associated corneal lesions. The pathogens identified on conjunctival smears and cultures in cases of acute bacterial conjunctivitis are given in Table 1 . The bacterial infection was mixed in majority of the patients. A general physical examination was made in every patient, and those who had no ocular or systemic affliction other than the conjunctival disease were chosen. None of the patients received any medication before or at the time of the study.
Stimulated tear samples of 100 to 200 ,ul were collected by a method described previously'" and stored at -20°C until assayed. Lysozyme was quantified by a single radial immunodiffusion technique originally described by Mancini et al. 6 after diluting the tear samples 1:25 with phosphate buffered saline (pH 7 4) . The technique has been described in detail.'4 Monospecific rabbit antihuman lysozyme serum and the reference standard were obtained from Behring Institute, West Germany. A standard curve was constructed for each plate and the concentration of lysozyme in tear samples was determined with reference to the standard curve.
Results
The age and sex distribution of normal people and the patients are given in Table 2 . Tear lysozyme was found in all the samples in measurable quantity. In normal people the overall mean value oftear lysozyme was 1 *334+0*69 mg/ml. (SI conversion: mg/ml=g/l.) There was no significant difference (t= 1-07, DF 109, p>030) between the levels in males (1-41+0-70 mg/ml) and that in females (1-27+0-67 mg/ml). The tear lysozyme levels in the different age groups are shown in Table 3 . It can be seen that the lysozyme level was low in the young, rose with age, and started falling after the age of30 years. Since the tear lysozyme level in normal people varied with age, it was necessary for comparison to take separate controls matched for age from among the normal people for each disease group.
The mean levels of tear lysozyme in controls matched for age and in the disease groups are given in Table 4 . The mean tear lysozyme was significantly decreased in the cases of nutritional deficiency with epithelial xerosis (p<0-01) and in chronic irritative conjunctivitis (p<0001) as compared with normal healthy people of the respective age groups. It was not significantly altered in vernal conjunctivitis, phlyctenular conjunctivitis, and acute bacterial conjunctivitis. The mean tear lysozyme in patients with trachoma with superimposed acute bacterial conjunctivitis was compared with that in patients with trachoma after matching for age, and the difference failed to attain statistical significance (p>0 05).
Discussion
The techniques employed for the estimation of tear lysozyme were difficult for routine application and for comparison, and the values obtained varied widely.45 718 Bonavida and Sapse'9 introduced a method based on the bacteriolytic action of lysozyme on the cell wall of Micrococcus lysodeikticus. Johansson and Malmquist20 observed that the bacteriolytic SI conversion: mg/ml=g/l. lysozyme determination is not a specific enzyme assay and is probably influenced to some extent by factors other than the lysozyme activity. To avoid such influences tear lysozyme levels were measured by a single radial immunodiffusion method. Anderson'3 studied cases of epithelial xerosis and found the tear lysozyme to be much lower. Present findings are in agreement with his observations. Thompson and Gallardo'2 and Harada and associ-ates2" have shown that the chief sources of lysozyme in tears is the lacrimal gland rather than the mucous gland of the conjunctiva. It is therefore assumed that the cases of nutritional deficiency with epithelial xerosis have a decreased production of the enzyme by the lacrimal gland.
Ridley' reported a low level of lysozyme in tears in phlyctenular conjunctivitis and considered it to be due to associated excessive tearing. However, recent studies have shown that there is no correlation between the titre of lysozyme in the tear fluid and the rate of tear floW. 11922 We did not find the tear lysozyme level in this disease to be significantly different from that of healthy subjects.
Erickson and associates'8 reported the tear lysozyme level to be low in eyes exposed to industrial fumes. The present findings are similar. This low level may be due to destruction of lysozyme in the conjunctival sac or to binding of the lysozyme locally to the tissue by noxious agents. " Reports on the tear lysozyme level in patients with acute bacterial conjunctivitis are contradictory.4 12 23 24 Some authors have reported a low level of tear lysozyme in these patients and attributed this to excessive tearing associated with the disease.423 It has already been pointed out that excessive tearing does not alter the lysozyme level in tears.8 9 11 22 Janke and associates24 on the other hand observed that the lysozyme level was probably slightly higher in acute bacterial conjunctivitis. Gordon and associates25 and McClelland and van Furth26 have demonstrated that the neutrophils contain lysozyme which is liberated from them during degeneration and cell death. Therefore the lysozyme content of tears from patients with acute bacterial conjunctivitis may be expected to be high. However, no significant alteration was found in the tear lysozyme level in such patients as compared with controls. This indicates that the neutrophils present in tears of such patients are not numerous enough to contribute significantly to the lysozyme content of tears.
The tear lysozyme levels in patients with trachoma have been reported to be low.'4 This low lysozyme level in patients with trachoma probably makes them more vulnerable to secondary bacterial infections, which are frequently associated with trachoma. Ridley27 had stated that while the normal lysozyme content of tears might be effective against some pathogenic bacteria, the lysozyme level needed to be decreased only very slightly to be totally ineffective against all pathogens. A group of patients with trachoma were examined as concurrent controls for the group of patients with trachoma superimposed with acute bacterial conjunctivitis. There was no significant difference in the tear lysozyme levels between the 2 groups. This again suggests that acute bacterial conjunctivitis does not alter the lysozyme level in tears significantly.
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